$1.31
-0.04-2.96%
At close: -
$1.32
0.010.76%
After Hours: Mar 20, 7:21 PM EDT
Comments
Loading...
Evogene Earnings Estimates, EPS & Revenue | NASDAQ:EVGN | Benzinga
Evogene reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 22
EPS Estimate
$-0.730
Quarterly Revenue Estimate
$4.00M
Annual Revenue
(as of Sep 30)
(as of Sep 30)
$7.48M
Analyze the earnings history of Evogene using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| EVGN | Evogene | -$0.80 | -$0.73 | — | — | $4.19M | $4.00M | — | — | 05/22/2025 | Get Alert |
| EVGN | Evogene | -$1.30 | -$0.73 | $0.06 | 108.22% | $578.00K | $3.62M | $1.61M | -55.50% | 03/06/2025 | Get Alert |
| EVGN | Evogene | -$0.81 | -$1.01 | -$1.31 | -29.70% | $3.77M | $2.85M | $1.80M | -36.98% | 11/21/2024 | Get Alert |
| EVGN | Evogene | -$1.68 | -$1.20 | -$1.06 | 11.67% | $654.00K | $800.00K | $914.00K | 14.25% | 08/22/2024 | Get Alert |
| EVGN | Evogene | -$1.50 | -$0.90 | -$0.80 | 11.11% | $641.00K | $3.50M | $4.19M | 19.71% | 05/23/2024 | Get Alert |
| EVGN | Evogene | -$0.70 | -$1.40 | -$1.30 | 7.14% | $660.00K | $910.00K | $578.00K | -36.48% | 03/07/2024 | Get Alert |
| EVGN | Evogene | -$1.60 | -$1.60 | -$0.80 | 50.00% | $466.00K | $1.18M | $3.77M | 219.24% | 11/15/2023 | Get Alert |
| EVGN | Evogene | -$2.10 | -$1.70 | -$1.70 | 0.00% | $312.00K | $880.00K | $654.00K | -25.68% | 08/17/2023 | Get Alert |
| EVGN | Evogene | -$2.00 | -$1.60 | -$1.50 | 6.25% | $237.00K | $870.00K | $641.00K | -26.32% | 05/18/2023 | Get Alert |
| EVGN | Evogene | -$1.80 | -$2.00 | -$0.70 | 65.00% | $311.00K | $420.00K | $660.00K | 57.14% | 03/09/2023 | Get Alert |
| EVGN | Evogene | -$1.90 | $2.00 | -$1.60 | -180.00% | $151.00K | $100.00K | $466.00K | 366.00% | 11/17/2022 | Get Alert |
| EVGN | Evogene | -$1.50 | -$1.70 | -$2.10 | -23.53% | $135.00K | $270.00K | $312.00K | 15.56% | 08/31/2022 | Get Alert |
| EVGN | Evogene | -$1.70 | — | -$2.00 | — | $333.00K | — | $237.00K | — | 05/26/2022 | Get Alert |
| EVGN | Evogene | -$2.50 | -$1.70 | -$1.80 | -5.88% | $351.00K | $270.00K | $311.00K | 15.19% | 03/10/2022 | Get Alert |
| EVGN | Evogene | -$1.70 | -$1.70 | -$1.90 | -11.76% | $316.00K | $270.00K | $151.00K | -44.07% | 11/17/2021 | Get Alert |
| EVGN | Evogene | -$1.70 | -$1.80 | -$1.50 | 16.67% | $298.00K | $300.00K | $135.00K | -55.00% | 08/11/2021 | Get Alert |
| EVGN | Evogene | -$2.40 | — | -$1.70 | — | $75.00K | $300.00K | $333.00K | 11.00% | 05/26/2021 | Get Alert |
| EVGN | Evogene | -$2.40 | — | -$2.50 | — | $116.00K | — | $351.00K | — | 03/03/2021 | Get Alert |
| EVGN | Evogene | -$1.60 | — | -$1.70 | — | $97.00K | $1.90M | $316.00K | -83.37% | 11/18/2020 | Get Alert |
| EVGN | Evogene | -$1.60 | — | -$1.60 | — | $192.00K | $1.90M | $298.00K | -84.32% | 08/05/2020 | Get Alert |
| EVGN | Evogene | -$1.50 | — | -$2.40 | — | $348.00K | $1.90M | $75.00K | -96.05% | 05/26/2020 | Get Alert |
Evogene (EVGN) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-06 | $0.06 | $-0.73 | 108.2 % |
| Q3 | 2024-11-21 | $-1.31 | $-1.01 | -29.7 % |
| Q2 | 2024-08-22 | $-1.06 | $-1.20 | 11.7 % |
| Q1 | 2024-05-23 | $-0.80 | $-0.90 | 11.1 % |
Evogene (EVGN) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-06 | $1.61M | $3.62M | -55.5 % |
| Q3 | 2024-11-21 | $1.80M | $2.85M | -37.0 % |
| Q2 | 2024-08-22 | $914.00K | $800.00K | 14.2 % |
| Q1 | 2024-05-23 | $4.19M | $3.50M | 19.7 % |
FAQ
When is Evogene (NASDAQ:EVGN) reporting earnings?
Evogene (EVGN) is scheduled to report earnings on May 22, 2025. The last reported earnings were for reported on March 6, 2025 for Q4.
What were the latest earnings per share (EPS) for Evogene (NASDAQ:EVGN)?
The Actual EPS was $0.06, which beat the estimate of $-0.73.
What were Evogene’s (NASDAQ:EVGN) revenues?
The Actual Revenue was $1.6M, which missed the estimate of $3.6M.
Browse earnings estimates, EPS, and revenue on all stocks.